Tag: Entrepreneurship

Opportunities

Last Days to Apply for MIEHT: Applications Close April 30

There is still time to apply for the Medical Innovation and Entrepreneurship Honors Track (MIEHT), but the deadline is quickly approaching. Applications for the next MIEHT cohort will close on April 30. Hosted by BioVentures at UAMS, MIEHT is a four-year honors track designed for medical students who want to build the skills to identify unmet clinical needs, develop practical healthcare solutions, and explore the path from innovation to implementation. The program gives students hands-on exposure to clinical problem-solving, customer discovery, early-stage innovation, and healthcare entrepreneurship. Through MIEHT, participants learn how to move beyond identifying problems in medicine to actively designing solutions that improve care delivery, clinical workflows, and patient outcomes. Students in the program gain access to mentorship, innovation frameworks, commercialization guidance, and a growing community of clinician-innovators working to improve healthcare from within. MIEHT is designed for students interested in innovation, translational problem-solving, and the future of healthcare, whether their interests lie in devices, systems, workflows, or new models of care. If you are interested in becoming part of the next cohort, now is the time to apply. Applications close April 30. Click here to Apply Now

Read More »
Events

HSIE Grand Rounds to Feature Jeff Moran

Jeff Moran, Ph.D., CEO of PinPoint Testing LLC, will be the featured speaker at 2 p.m. on Thursday, May 7, 2026, for the Health Sciences Innovation & Entrepreneurship (HSIE) Grand Rounds. His presentation, From Concept to Venture: Building Entrepreneurial Success from the Ground Up, will explore the process of translating ideas into successful ventures, drawing on his extensive experience in analytical toxicology and public health laboratory leadership.  Join us at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, 10th Floor, Betsy Blass Boardroom.  The UAMS community and the public are welcome to attend. 

Read More »
Events

BioVentures and ARise Host Founder’s Forum to Equip UAMS Innovators with Fundraising Strategies  

BioVentures, in partnership with ARise, brought together emerging innovators and entrepreneurs for the first Founder’s Forum, a program designed to support UAMS-affiliated startup founders and teams working to translate research into real-world impact.  ARise, a program supporting Arkansas innovators, startups, and entrepreneurs and backed by the Arkansas Economic Development Commission (AEDC), assists tech and tech-enabled companies in reaching new levels of success.  The session featured Melissa Kempkes, Executive Director of Ark Angel Alliance and ARise subject-matter expert, who led an engaging discussion on fundraising strategies for bio startups. Drawing on her experience working with early-stage companies and investors, Kempkes provided practical guidance to help founders navigate the complexities of securing capital—from initial exploration to active company building.  The Founder’s Forum serves as a dynamic platform for UAMS biotech startup founders at all stages, from those exploring commercialization pathways to those actively building and scaling ventures.  Through this ongoing series, BioVentures and ARise are strengthening the UAMS innovation ecosystem by connecting founders with expert insights, resources, and a growing network of support.  “Programs like Founder’s Forum are critical to helping innovators move beyond the lab and into the marketplace,” said Eric Peterson, President of BioVentures. “By bringing together experienced leaders and emerging founders, we’re accelerating the path from discovery to impact.”  BioVentures and ARise remain committed to empowering UAMS entrepreneurs and advancing innovations that improve health and drive economic growth across Arkansas and beyond. 

Read More »
Blog

Applications Now Open for BioVentures’ Medical Innovation and Entrepreneurship Honors Track (MIEHT) 

The MIEHT program offers structured training in need identification, customer discovery, problem triaging, and iterative solution development. Through seminars, hands-on exploration, and mentorship, students gain practical experience in evaluating clinical challenges and advancing innovative concepts that can improve patient care and healthcare system efficiency. 

Read More »
Blog

From Disclosure to Market: How the BioVentures Process Works 

Curious how an idea becomes a protected invention at UAMS?  At BioVentures, we guide innovators through every step, from disclosure to patent decisions and market strategy. Here’s how the process works, what to expect, and how we support you along the way. 1) Submit Your Invention Disclosure  The first step is fully and adequately disclosing your invention to BioVentures by submitting an invention disclosure. Even if you’ve already reached out to schedule a meeting, we require a disclosure to initiate the process. It allows us to review the technology in advance, and gather essential information on compliance, funding, and inventorship.  We’ve recently adopted a new AI-powered disclosure platform to simplify the process. You can upload relevant documents—papers, figures, posters, presentations—and the system will generate a draft disclosure for you to review and edit before submission:  👉 Submit your disclosure  The form captures a complete overview of your invention, its potential applications, and any existing data or prototypes. Once submitted, BioVentures typically reviews the disclosure within 1–2 weeks before scheduling a meeting with you.  Typical timing: BioVentures review in 1–2 weeks.  2) Meeting with the Technology Manager  We meet with the inventor to clarify the technology, confirm federal compliance needs, capture inventor and funding information, and discuss long‑term goals and commercialization paths.  Typical timing: Scheduled within 1–2 weeks after disclosure review.  3) P&CC Decision (Patent & Copyright Committee)  The inventor presents at the P&CC. This committee reviews the presented technology and makes a determination on how the technology should be protected. Outcomes can include:  Typical timing: P&CC is usually scheduled 1–2 months after acceptance of the disclosure.  4) Protection Strategy Based on P&CC Outcome  The legal protection route follows the P&CC decision. If a provisional patent filing is recommended, we move quickly to secure a priority date and a 12‑month window to strengthen data and assess market potential. This is because in the United States is a first to file country which means that the right to a patent generally belongs to whichever inventor files an application with the USPTO first, not to whoever first conceives the idea. As such, protecting your invention in a timely manner is important to us.   Typical timing: Provisional filing is typically completed within a few weeks of the P&CC meeting.  5) Marketing and Commercial Pathways  If the inventor agrees, we begin targeted outreach. Options include:  Why Early Disclosure Matters  Submitting your invention disclosure early is essential. It helps preserve your patent rights before any public disclosure or publication, ensuring your ability to pursue protection. Early disclosure also allows BioVentures to align your IP strategy with funding sources and compliance requirements, and accelerates our ability to evaluate the market potential and identify relevant partners.  This overview is for general information and does not constitute legal advice. Specific strategies and timelines may vary by technology.  Have an invention to disclose? Submit your disclosure now!

Read More »
Blog

BioVentures Supports UAMS M1 Students in PCAR Summer Program

BioVentures supported University of Arkansas for Medical Sciences (UAMS) first-year medical students this summer through the Partnership in Cancer Research (PCAR) program. Over eight weeks, participants worked in multidisciplinary teams to address real-world challenges in cancer prevention, diagnosis, treatment, or survivorship. The program culminated in entrepreneurial pitch presentations to a panel of judges. Three BioVentures team members served as mentors, advising students on refining problem statements, assessing market opportunities, and developing business models. Another team member participated as a judge, providing feedback from a commercialization perspective. The collaboration aimed to foster entrepreneurial thinking, highlight the role of innovation in cancer care, and encourage future clinician-innovators at UAMS. This initiative reflects BioVentures’ ongoing commitment to advancing healthcare entrepreneurship and translating research into real-world impact.

Read More »
Events

BioVentures Innovation Week to Celebrate Innovation & Entrepreneurship at UAMS 

BioVentures invites the UAMS community to Innovation Week, May 12-15, 2025.  Designed to showcase innovation, foster industry connections and highlight the pathway from research to commercialization, Innovation Week offers opportunities for everyone from seasoned inventors and those just starting out.  Whether you’re an entrepreneur, inventor, researcher or industry partner, Innovation Week is your chance to engage with the thriving healthcare innovation ecosystem at UAMS and beyond.  Innovation Week Highlights  Join us to learn, connect and take your ideas to the next level.   Learn more & register.

Read More »